Stay updated on Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Adds Minnesota as a Location under the Locations section (revision v3.3.3) and removes the HHS Vulnerability Disclosure and Minnesota Locations entries (revision v3.3.2).
    Difference
    0.2%
    Check dated 2025-12-24T02:38:16.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate that publications are automatically filled from PubMed, and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:43:21.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Removal of the government funding lapse notice banner from the page; this change does not affect study details, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:21:16.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The update appears limited to minor formatting and a new update date, with no changes to the core study details (interventions, eligibility, outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:25:17.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T05:56:54.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    Updated version tag to v3.1.0; removed explicit mention of an older revision v3.0.2. No other substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:14:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ibrutinib in Stage III-IV Melanoma Clinical Trial page.